Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  CHOLESTEROL AND OTHER CARDIOVASCULAR TESTING
A Global Strategic Business Report

This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Million Units by the following product segments: Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 48 companies including many key and niche players such as AccuTech, LLC, Axis-Shield PLC, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Home Access Health Corporation, Inverness Medical Innovations, Inc., Biosite Inc., Cholestech Corporation, Polymer Technology Systems, Inc., and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3403  PAGES:    320
PRICE:    $3950  DATE:       October 2008
COMPANIES:  48  MARKET DATA TABLES:   135
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  CHOLESTEROL AND OTHER CARDIOVASCULAR TESTING (Complete Report) Pages : 320   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS3$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
Quantitative Techniques & Analytics.....I-2
  
   Product Definitions and Scope of Study.....I-3
Lipid Panel Test/Complete Lipid Profile.....I-3
Total Cholesterol Test.....I-3
HDL Cholesterol Test.....I-3
Apolipoprotein B.....I-3
Other Apolipoprotein Tests.....I-3
  
II. EXECUTIVE SUMMARY63$2250
  1. Industry Overview.....II-15 $800  
   Global Market Outlook.....II-1
No-Holds Barred Growth.....II-1
Tests Conducted Worldwide.....II-1
Analysis by Geographic Region.....II-1
1$100
   Analysis by Product Segment.....II-2
Home/OTC Cholesterol Test Kits Market Set for Double-Digit Growth.....II-2
Growth Drivers.....II-2
Aging Population Drives Home Testing Market.....II-2
Extensive Awareness Campaigns for Common People.....II-2
1$100
   Global In-Vitro Diagnostic Products Market: An Overview.....II-31$100
   Growth Trends.....II-4
Table 1: World In-Vitro Diagnostic (IVD) Testing Market (2004): Percentage Breakdown by Value Sales for United States, Europe, Japan, Asia-Pacific, and Rest of World (includes corresponding Graph/Chart).....II-4
Established Players Dominate a Fragmented Industry.....II-4
1$350
   Table 2: Leading Players in the Global In-Vitro Diagnostics Market (*) (2006): Percentage Breakdown of Value Sales for Roche, Abbott, Siemens, Beckman Coulter, Dade Behring and Others.....II-5
Cardiac IVD Market to Grow.....II-5
1$350
  2. An Insight into Cardiovascular Diseases.....II-63 $300  
   The Heart of Heart Problems.....II-6
Types of Cardiovascular Diseases/Disorders.....II-6
Coronary Artery Disease.....II-6
Hyperlipidemia – An Important Risk Factor of Heart Disease.....II-6
1$100
   Hypertension – The Silent Killer.....II-71$100
   Two-Pronged Approach to Counter CVD.....II-8
Cardiovascular Risk Assessment.....II-8
1$100
  3. Good & Bad of Cholesterol.....II-93 $300  
   Blood Cholesterol – The Principal Cardiac Risk Marker.....II-9
Types of Cholesterol.....II-9
Total Cholesterol (TC).....II-9
High Density Lipoprotein (HDL).....II-9
1$100
   Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL).....II-10
Triglycerides (TRG).....II-10
Glucose (GLU).....II-10
Alanine Aminotransferase (ALT).....II-10
Outcomes of High Blood Cholesterol.....II-10
Atherosclerosis.....II-10
Coronary Heart Disease (CHD).....II-10
Risk Factors and Risk Levels.....II-10
Risk Factors.....II-10
1$100
   Risk Levels.....II-11
Risk Level Based on Total Cholesterol Concentration.....II-11
LDL-Cholesterol Risk Levels.....II-11
HDL-Cholesterol Risk Levels.....II-11
Triglyceride Risk Levels.....II-11
1$100
  4. Cholesterol Testing & CVD Risk Assessment Techniques.....II-1210 $800  
   Cholesterol Testing.....II-12
Need for Cholesterol Testing.....II-12
Candidates for Cholesterol Testing.....II-12
1$100
   Test Procedure.....II-13
Time of Testing – Crucial for Heart Disease Patients.....II-13
1$100
   Types of Cholesterol Testing.....II-14
Lipid Panel Test/Lipid Profile.....II-14
Total Cholesterol Test.....II-14
HDL Cholesterol Test.....II-14
1$100
   Apolipoprotein Tests.....II-15
Apolipoprotein A-1 Test.....II-15
Apolipoprotein B100 Test.....II-15
ApoE Genotyping Test.....II-15
1$100
   Apolipoprotein CII.....II-16
Table 3: Prices of Cholesterol Tests by Type.....II-16
Other Cholesterol Markers.....II-16
LDL Cholesterol Testing.....II-16
LDL Cholesterol Test – The First Cholesterol Testing Method.....II-16
Triglycerides/VLDL Cholesterol Testing.....II-16
1$350
   RLP Cholesterol.....II-17
Non Instrumented Technologies.....II-17
Heart Disease Diagnosis Tests.....II-17
Non-Invasive Tests.....II-17
Invasive Tests.....II-17
1$100
   Other CVD Markers.....II-18
Creatine Kinase MB.....II-18
Troponin T and Troponin I.....II-18
1$100
   Myoglobin.....II-19
P-selectin Profile.....II-19
C-reactive Protein.....II-19
1$100
   Endothelial Dysfunction.....II-20
Homocysteine.....II-20
1$100
   Plasminogen Activator Inhibitor-1.....II-21
s-100 Protein.....II-21
Thrombus Precursor Protein.....II-21
Other Cardiac Markers.....II-21
1$100
  5. Point of Care & Home Cholesterol Testing.....II-222 $650  
   Point of Care (POC) Medical Diagnostics.....II-22
Table 4: Global Point of Care Diagnostics Market (2006): Percentage Breakdown of Value Sales by Segment – Hospital Labs, Commercial Labs, Self Testing and Point of Care.....II-22
1$350
   POC Testing Market.....II-23
Table 5: Global Cholesterol Point-of-Care Rapid Tests Market (2009): Market Shares of Leading Players by Value Sales for Inverness, Roche, Abaxis, and Others (includes corresponding Graph/Chart).....II-23
Development of Home Cholesterol Testing Kits.....II-23
Table 6: Cholesterol and Other Cardiovascular Test Kits Offered by Leading Companies.....II-23
1$350
  6. Cholesterol Control & Treatment Modalities.....II-243 $300  
   Prevention is Better than Cure.....II-24
Dietary Therapy.....II-24
Healthy Diet.....II-24
1$100
   Exercises.....II-25
Drug Therapy.....II-25
Classification of Cholesterol Lowering Drugs.....II-25
Bile Acid Sequestrants.....II-25
Nicotinic Acid.....II-25
1$100
   HMG CoA Reductase Inhibitors (Statins).....II-26
Other Drugs (Fibric Acids and Probucol).....II-26
Testing After Commencing Drug Therapy.....II-26
1$100
  7. Product Innovations/Launches.....II-274 $400  
   Home Access Health Launches CheckUp America Cholesterol Panel.....II-27
Cholestech Launches Lipid Profile*ALT Test Cassette.....II-27
Home Access Health Develops an Algorithm for Home Test.....II-27
Cholestech Unveils Innovative Dermatology Kit.....II-27
1$100
   Beckman Coulter Unveils UniCel® DxI 600 Access® Immunoassay System.....II-28
Polymer Technology Systems to Launch Direct LDL Cholesterol Test.....II-28
1$100
   Dade Behring Unveils CardioPhase(R) hsCRP Test.....II-29
PTS to Distribute First Ever Direct LDL Cholesterol Test.....II-29
Liposcience Reinstates Blood Cholesterol Test.....II-29
Akers Launches Tri-Cholesterol Test.....II-29
1$100
   Dade Behring Unveils Homocysteine Test on BN(TM) Systems.....II-30
Axis-Shield Introduces BNP Assay for IMx® system of Abbott.....II-30
Roche Unveils Cardiac pro-BNP Test.....II-30
Accutech Introduces a new Diagnostic Test called CholesTrak for Women.....II-30
1$100
  8. Recent Industry Activity.....II-3110 $600  
   TRICARE Includes Atherotech’s VAP® Test.....II- 31
PreMD Receives NSE Letter from US FDA for POC Skin Cholesterol Test.....II-31
Amic Gains License for Roche’s Cardiac Marker.....II-31
1$100
   Acrongenomics and Molecular Vision Enter into Joint Collaboration Agreement.....II-32
diaDexus and Fisher HealthCare Sign Agreement.....II-32
Beckman Coulter Partners for Cardiovascular Research Project.....II-32
1$100
   Siemens Acquires Bayer’s Diagnostic Division.....II-33
Response Biomedical Gains Approval to Sell RAMII® NT- proBNP Test.....II-33
Endothelix Obtains FDA Approval for VENDYS® Cardiovascular Test.....II-33
Cholestech Receives CLIA Waived Status for Lipid Profile ALT Test Panel.....II-33
1$100
   Kellogg Partners with Omron Healthcare and BIOSAFE®.....II-34
Siemens Acquires Dade Behring.....II-34
Inverness Medical Innovations Concludes Cholestech Acquisition.....II-34
1$100
   QuantRX Biomedical Increases Stake in FluoroPharma **Relevance.....II-35
Celera Takes Over Berkeley HeartLab.....II-35
Inverness Medical Innovations Completes Acquisition of HemoSense.....II-35
LipoScience and BioReference Announce Collaboration.....II-35
1$100
   PreMD and AstraZeneca Sign Distribution Agreement.....II-36
Atherotech Reaches an Agreement with Source Scientific.....II-36
Siemens Acquires Diagnostic Products Corporation.....II-36
1$100
   Nanogen Acquires Spectral’s Cardiac Test Division.....II-37
Instant Technologies Takes Over Accu-Stat Diagnostics.....II-37
Source Scientific and Atherotech Collaborate for VAP Test Devices.....II-37
Abbott Receives Non-exclusive Sublicense for Diagnostic Use of PIGF.....II-37
1$100
   Cholestech to Supply LDX® System to Mexican Ministry of Communications &
  Tranportation.....II-38
PTS Enters into a Distribution Agreement with Medical Home Products.....II-38
Olympus’ AU3000i to Expand Market for Bayer’s BNP Assay.....II-38
PTS to Provide Test Strips to Lifestream Technologies for New Cholesterol/HDL
  Test.....II-38
Skylight Biotech to Start Cholesterol Testing Center for Animals.....II-38
1$100
   FDA Grants CLIA Waiver for Biosite’s Triage(R) BNP Test.....II-39
Response Biomedical Wins Nonexclusive License Rights for NT-proBNP and Troponin
  T.....II-39
Medicure Gains Licensing Rights of Cholesterol- Lowering Technology.....II-39
Atherotech Collaborates with Resverlogix Corp.....II-39
IMI Enters into an Agreement with McNeil.....II-39
1$100
   Nymox Pharmaceutical Receives Patent for Saliva Cholesterol Test.....II-40
LabCorp Ties Up with Atherotech to Offer VAP Cholesterol Test.....II-40
ABAXIS Bags FDA Approval for Three Assays.....II-40
Cholestech Obtains Approval to Market its Cholestech GDX™ System in Canada.....II-40
1$100
  9. Focus on Select Global Players.....II-415 $500  
   AccuTech, LLC (US).....II-41
Axis-Shield Plc (UK).....II-41
Beckman Coulter, Inc. (US).....II-41
1$100
   F. Hoffmann-La Roche Ltd (Switzerland).....II-42
Home Access Health Corporation (US).....II-42
1$100
   Inverness Medical Innovations, Inc. (US).....II-43
Biosite, Inc. (US).....II-43
1$100
   Cholestech Corporation (US).....II-44
Polymer Technology Systems, Inc. (USA).....II-44
1$100
   Siemens Healthcare Diagnostics, Inc. (USA).....II-45
1$100
  10. Global Market Perspective.....II-46   
   Table 7: World Recent Past, Current & Future Market Analysis for Cholesterol & Other Cardiovascular Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-461$350
   Table 8: World Long-term Projections for Cholesterol & Other Cardiovascular Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-471$350
   Table 9: World 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-481$350
   Table 10: World Recent Past, Current & Future Market Analysis for Lipid Panel Test/Complete Lipid Profile Test by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-491$350
   Table 11: World Long-term Projections for Lipid Panel Test/ Complete Lipid Profile Test by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-501$350
   Table 12: World 10-Year Perspective for Lipid Panel Test/ Complete Lipid Profile Test by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-511$350
   Table 13: World Recent Past, Current & Future Market Analysis for Total Cholesterol Testing by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-521$350
   Table 14: World Long-term Projections for Total Cholesterol Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-531$350
   Table 15: World 10-Year Perspective for Total Cholesterol Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-541$350
   Table 16: World Recent Past, Current & Future Market Analysis for HDL Cholesterol Testing by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-551$350
   Table 17: World Long-term Projections for HDL Cholesterol Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-561$350
   Table 18: World 10-Year Perspective for HDL Cholesterol Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-571$350
   Table 19: World Recent Past, Current & Future Market Analysis for Apolipoprotein B Tests by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-581$350
   Table 20: World Long-term Projections for Apolipoprotein B Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-591$350
   Table 21: World 10-Year Perspective for Apolipoprotein B Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-601$350
   Table 22: World Recent Past, Current & Future Market Analysis for Other Apolipoprotein Tests by Geographic Region –United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-611$350
   Table 23: World Long-term Projections for Other Apolipoprotein Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-621$350
   Table 24: World 10-Year Perspective for Other Apolipoprotein Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-631$350
III. MARKET65$1950
  1. The United States.....III-120 $1675  
   A. Market Analysis.....III-1
Market Outlook.....III-1
Cardiovascular Market: Startling Statistics.....III-1
1$75
   Table 25: Prevalence of Cardiovascular Disease (CVD) in the US: Population by Disease Type (in 000s) (includes corresponding Graph/Chart).....III-2
Cholesterol Testing – NCEP Recommendations Spurs Potential.....III-2
1$200
   Trends and Issues.....III-3
Innovations Drive the Usage of Cardiovascular Monitoring Systems.....III-3
Sterols and Stanols: Cholesterol-lowering Products.....III-3
Cholesterol POCT Market: An Overview.....III-3
1$75
   Table 26: US Cholesterol Point-of-Care Testing (2009): Market Shares of Leading Players by Value Sales for Inverness Medical, Polymer Technology Systems, and Roche Diagnostics (includes corresponding Graph/Chart).....III-4
Increasing Cardiovascular Ailments Drive Sales of Home Test Devices.....III-4
Table 27: US Recent Past, Current & Future Analysis for Home Cholesterol Monitoring Kits: Annual Sales Figures in US$ Million for Years 2000 through 2010.....III-4
1$200
   Product Innovations/Launches.....III-52$150
   Strategic Corporate Developments.....III-77$525
   Key Players.....III-14
AccuTech, LLC.....III-14
1$75
   Beckman Coulter, Inc......III-15
Home Access Health Corporation.....III-15
Inverness Medical Innovations, Inc......III-15
1$75
   Biosite, Inc......III-16
Cholestech Corporation.....III-16
1$75
   Polymer Technology Systems, Inc......III-17
Siemens Healthcare Diagnostics, Inc......III-17
1$75
   B. Market Analytics.....III-18
Table 28: US Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-18
1$200
   Table 29: US Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-191$200
   Table 30: US 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-20
1$200
  2. Canada.....III-215 $650  
   A. Market Analysis.....III-21
Market Outlook.....III-21
Strategic Corporate Developments.....III-21
2$150
   B. Market Analytics.....III-23
Table 31: Canadian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test / Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-23
1$200
   Table 32: Canadian Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includescorresponding Graph/Chart).....III-241$200
   Table 33: Canadian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-25
1$200
  3. Japan.....III-264 $700  
   A. Market Analysis.....III-26
Market Outlook.....III-26
Home Cholesterol Monitoring Kits Market.....III-26
Table 34: Japanese Recent Past, Current & Future Analysis for Home Cholesterol Monitoring Kits Market: Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-26
1$200
   B. Market Analytics.....III-27
Table 35: Japanese Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-27
1$200
   Table 36: Japanese Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-281$200
   Table 37: Japanese 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-29
1$200
  4. Europe.....III-307 $1100  
   A. Market Analysis.....III-30
Market Outlook.....III-30
Home Cholesterol Monitoring Kits Market in Western Europe.....III-30
Table 38: Western Europe Market for Home Cholesterol Monitoring Kits - Recent Past, Current & Future Analysis: Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-30
Strategic Corporate Developments.....III-30
1$200
   B. Market Analytics.....III-31
Table 39: European Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Geographic Region – France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-31
1$200
   Table 40: European Long-term Projections for Cholesterol & Other Cardiovascular Testing by Geographic Region – France, Germany, Italy, UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-321$200
   Table 41: European 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Geographic Region – Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain,Russia & Rest of Europe Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-331$200
   Table 42: European Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-341$200
   Table 43: European Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-351$200
   Table 44: European 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-36
1$200
  4a. France.....III-373 $525  
   Market Analysis.....III-37
Table 45: French Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-37
1$200
   Table 46: French Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-381$200
   Table 47: French 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-39
1$200
  4b. Germany.....III-403 $525  
   Market Analysis.....III-40
Table 48: German Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-40
1$200
   Table 49: German Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-411$200
   Table 50: German 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-42
1$200
  4c. Italy.....III-433 $525  
   Market Analysis.....III-43
Table 51: Italian Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-43
1$200
   Table 52: Italian Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-441$200
   Table 53: Italian 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-45
1$200
  4d. United Kingdom.....III-464 $600  
   A. Market Analysis.....III-46
Key Player.....III-46
Axis-Shield Plc.....III-46
Product Launches.....III-46
1$75
   B. Market Analytics.....III-47
Table 54: UK Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-47
1$200
   Table 55: UK Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-481$200
   Table 56: UK 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-49
1$200
  4e. Spain.....III-503 $525  
   Market Analysis.....III-50
Table 57: Spanish Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment –Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-50
1$200
   Table 58: Spanish Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-511$200
   Table 59: Spanish 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-52
1$200
  4f. Rest of Europe.....III-534 $600  
   A. Market Analysis.....III-53
Key Player.....III-53
F. Hoffmann-La Roche Ltd.....III-53
Product Launch.....III-53
1$75
   Strategic Corporate Development.....III-54
B. Market Analytics.....III-54
Table 60: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment - Lipid Panel Test/Complete Lipid Profile,Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-54
1$200
   Table 61: Rest of Europe Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-551$200
   Table 62: Rest of Europe 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-56
1$200
  5. Asia-Pacific.....III-573 $525  
   A. Market Analysis.....III-57
Market Outlook.....III-57
B. Market Analytics.....III-57
Table 63: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test / Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-57
1$200
   Table 64: Asia-Pacific Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-581$200
   Table 65: Asia-Pacific 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-59
1$200
  6. Latin America.....III-603 $525  
   Market Analysis.....III-60
Table 66: Latin American Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/ Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-60
1$200
   Table 67: Latin American Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-611$200
   Table 68: Latin American 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-62
1$200
  7. Rest of World.....III-633 $600  
   Market Analysis.....III-63
Table 69: Rest of World Recent Past, Current & Future Analysis for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile,Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Test Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-63
1$200
   Table 70: Rest of World Long-term Projections for Cholesterol & Other Cardiovascular Testing by Product Segment – Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets Independently Analyzed with Annual Sales Figures in Million Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-641$200
   Table 71: Rest of World 10-Year Perspective for Cholesterol & Other Cardiovascular Testing by Product Segment – Percentage Breakdown of Unit Sales for Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests Markets for 2003, 2008 & 2012 (include corresponding Graph/Chart).....III-651$200
IV. COMPETITIVE LANDSCAPE 178$995
  
Total Companies Profiled: 48 (including Divisions/Subsidiaries - 57)

Region/Country                 Players


The United States                  40   
Canada                              1
Japan                               3
Europe                             11
     Germany                        1
     The United Kingdom             4
     Italy                          1
     Rest of Europe                 5
Asia-Pacific (Excluding Japan)      2
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.